We describe two patients admitted to our institution with a diagnosis of sexually acquired acute hepatitis B who also had underlying hyper acute HIV infection. Both individuals reported high rates of condomless sex. Antiviral therapy active against HBV and HIV was started within days after diagnosis. Treatment was well tolerated and led to a rapid control of both infections and hepatitis B surface antibody seroconversion. The efficacy and safety of contemporary antiretroviral drug combinations suggest that treatment of acute HIV infection is feasible in patients with acute hepatitis B.
BansalR., PolicarM., MehtaC.Acute hepatitis B and acute HIV coinfection in an adult patient: a rare case report.Case Rep Med2010; 2010: 820506.
4.
INSIGHT START Study Group, Lundgren JD, Babiker AG, et al.Initiation of antiretroviral therapy in early asymptomatic HIV infection.N Engl J Med2015; 373: 795–807.
5.
TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, et al.A trial of early antiretrovirals and isoniazid preventive therapy in Africa.N Engl J Med2015; 373: 808–822.
6.
StrainM.C., LittleS.J., DaarE.S.Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.J Infect Dis2005; 191: 1410–1418.
7.
SimonettiF.R., KearneyM.F.Review: influence of ART on HIV genetics.Curr Opin HIV AIDS2015; 10: 49–54.
8.
OxeniusA., PriceD.A., EasterbrookP.J.Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes.Proc Natl Acad Sci U S A2000; 97: 3382–3387.
9.
SPARTAC Trial Investigators, FidlerS., PorterK.Short-course antiretroviral therapy in primary HIV infection.N Engl J Med2013; 368: 207–217.
10.
WawerM.J., GrayR.H., SewankamboN.K.Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.J Infect Dis2005; 191: 1403–1409.
11.
CohenM.S., ChenY.Q., McCauleyM.Prevention of HIV-1 infection with early antiretroviral therapy.N Engl J Med2011; 365: 493–505.
12.
European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection.J Hepatol2012; 57: 167–185.
13.
ThioC.L.Hepatitis B and human immunodeficiency virus coinfection.Hepatology2009; 49: S138–S145.
14.
McGovernB.H.The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection.Antivir Ther2007; 12: H3–H13.
15.
PhungB.C., SogniP., LaunayO.Hepatitis B and human immunodeficiency virus co-infection.World J Gastroenterol2014; 20: 17360–17367.
16.
ThioC.L., SeabergE.C., SkolaskyR.HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).Lancet2002; 360: 1921–1926.
JansenK., ThammM., BockC.T.High prevalence and high incidence of coinfection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany.PLoS One2015; 10: e0142515.
HeuftM.M., HoubaS.M., van den BerkG.E.Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection.AIDS2014; 28: 999–1005.
21.
GatanagaH., HayashidaT., TanumaJ.Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.Clin Infect Dis2013; 56: 1812–1819.
